Individual HSPs or autologous tumor–antigenic peptides alone lack the ability to elicit an immune response; only HSPPCs can be endocytosed by APCs and activate CD4+ and CD8+ T cells, triggering an adaptive immune response against autologous tumor peptides [159,160]. This evidence concerns the gene CD4 and neoplasm.